Treatment of Inflammatory Bowel Disease with Biologics
Editat de Adam S. Cheifetz, Joseph D. Feuersteinen Limba Engleză Paperback – 5 sep 2018
Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 610.09 lei 38-44 zile | |
| Springer International Publishing – 5 sep 2018 | 610.09 lei 38-44 zile | |
| Hardback (1) | 1276.31 lei 38-44 zile | |
| Springer International Publishing – 22 noi 2017 | 1276.31 lei 38-44 zile |
Preț: 610.09 lei
Preț vechi: 642.20 lei
-5% Nou
Puncte Express: 915
Preț estimativ în valută:
116.77€ • 121.70$ • 97.21£
116.77€ • 121.70$ • 97.21£
Carte tipărită la comandă
Livrare economică 03-09 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319868233
ISBN-10: 3319868233
Pagini: 335
Ilustrații: XI, 335 p. 22 illus., 19 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.72 kg
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3319868233
Pagini: 335
Ilustrații: XI, 335 p. 22 illus., 19 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.72 kg
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Mechanism of Action and Pharmacokinetics of Biologics.- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis.- Anti-tumor Necrosis Factor Agents in Crohn’s Disease.- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease.- Use of Biologics in the Postoperative Management of Crohn’s Disease.- Biologics in Pregnancy and Breastfeeding.- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease.- Therapeutic Drug Monitoring of Biologic Agents.- Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks.- Cessation of Biologics – Can it be Done?.- Biologic Therapy in Pediatric Inflammatory Bowel Disease.- Infectious Complications of Biologics.- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy.- Non-infectious and Non-malignant Complications of Biologics.- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances.- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications.- Novel Agents in Inflammatory Bowel Disease.- Quality, Safety, and Practical Considerations of Using Biologic Therapies.
Notă biografică
Adam S. Cheifetz, MD
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Joseph D. Feuerstein, MD
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Joseph D. Feuerstein, MD
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Textul de pe ultima copertă
This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn’s disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field.
Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.
Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.
Caracteristici
Provides a comprehensive and state-of-the-art overview of using biologics to treat IBD Reviews best methods to effectively utilize biologics in the treatment of IBD Written by experts in the field Includes supplementary material: sn.pub/extras